# Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly

> **NCT01785979** · PHASE3 · WITHDRAWN · sponsor: **Lihir Medical Centre**

## Conditions studied

- Hyper-reactive Malarial Splenomegaly
- Malaria
- Anaemia

## Interventions

- **DRUG:** prednisone induction - chloroquine
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01785979
- **Lead sponsor:** Lihir Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785979, "Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01785979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*